Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: J Addict Med. 2022 Dec 13;17(3):356–359. doi: 10.1097/ADM.0000000000001113

Table 1.

Responses to study-created items

MOUD Misconceptions in Pregnancy/post-partum % Disagree Agree Not sure

It is safe to use MAT the entire time you are pregnant 8 76 15
MAT is the safest treatment option for pregnant women with addictions 12 73 15
Your MAT dosage will stay the same over the course of pregnancy* 52 20 28
The more MAT you take, the higher chance your baby will experience Neonatal Abstinence Syndrome (NAS)* 24 28 48
You need to take less MAT closer to the birth date* 36 16 48
If you start MAT while pregnant, your baby will experience withdrawal side effects 15 31 54
Your prenatal care provider needs to know your MAT dose 8 88 4
You do not need to meet with your MAT prescriber after birth* 73 12 15
Your doctor and MAT prescriber do not need to be in contact after birth* 77 8 15
You should keep the same dosage of MAT after birth* 15 38 46

Subjective Norms Mean SD

People who are important to me think I [should not – should] use MAT 5.42 2.0
People who are important to me would [disapprove – approve] of my using MAT 5.55 2.0
People who are important to me want me to use MAT: [Unlikely – Llikely] 5.79 1.8

Self-Efficacy Mean SD

How confident are you that you will continue to use MAT? [Not at all confident –Very confident] 5.96 1.66
How sure are you that you could continue to use MAT if you wanted to? [Not at all sure –Very sure] 6.00 1.66
For me, continuing MAT is: [very easy –very difficult] 5.58 1.79
How sure are you that you will be able to take MAT as prescribed? [Not at all sure –Very sure] 6.30 1.53
How much control do you have over whether you do or do not take MAT? [Very little control –Complete control] 5.94 1.71

Note:

*

Indicates items reverse-coded in scale construction. For subjective norms and self-efficacy, participants were displayed a numerical scale with with bracketed prompts on each end.